Comparative study of ROR2 and WNT5a expression in squamous/adenosquamous carcinoma and adenocarcinoma of the gallbladder

Figure 1 EnVision immunohistochemical staining of squamous carcinoma and adenosquamous carcinoma. A: Positive expression of ROR2 in moderately differentiated squamous carcinoma (SC); B: Negative expression of ROR2 in moderately differentiated SC; C: Positive expression of WNT5a in moderately differentiated adenosquamous carcinoma (ASC); D: Negative expression of WNT5a in poorly differentiated ASC. Microscopic view at × 200.

Figure 2 EnVision immunohistochemical staining for adenocarcinoma. A: Positive expression of ROR2 in highly differentiated adenocarcinoma (AC); B: Negative expression of ROR2 in highly differentiated AC; C: Positive expression of WNT5a in highly differentiated AC; D: Negative expression of WNT5a in poorly differentiated AC. A and C: × 200; B and D: × 400.

Figure 3 Survival curves for squamous/adenosquamous carcinoma. A: Positive and negative expression of ROR2 in squamous/adenosquamous carcinoma (SC/ASC); B: Positive and negative expression of WNT5a in SC/ASC.

Figure 4 Survival curves for adenocarcinoma. A: Positive and negative expression of ROR2 in AC; B: Positive and negative expression of WNT5a in AC.